Gw Pharma ADR (GWPH)
$84.52 0.48 (0.56%)
19:18 EDT GWPH Stock Quote Delayed 20 Minutes
Previous Close -
Market Cap 2.38B
PE Ratio -
Volume (Avg. Vol.) 351,100
Day's Range 82.57 - 87.67
52-Week Range 67.98 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
While the cannabis industry is facing headwinds, there are still some hidden gems capable of delivering hefty returns.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
These drug stocks all have tremendous potential as these small companies work to treat widespread diseases in the U.S. and beyond.
Demand for legal cannabis is not as strong as bulls predicted. As a result, investors should avoid big names like Aurora stock.
With U.S. stocks stretched, adventurous investors may want to seek better growth potential with European stocks.
Uber, Match Group, Kirkland Lake Gold, Humana and GW Pharma were our top stock trades from Wednesday. Let's look at the charts.
GW stock has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked cannabis stock.
These stocks to buy base at least some of their revenue on CBD and are poised to buck the downtrend that has hit the larger cannabis stocks.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Admittedly, GWPH stock could go either way before earnings. The sector in general has suffered amid falling prices for dried cannabis. With valuations still elevated, GWPH may need to offer a “perfect” report to keep the stock price from falling.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
Despite May's large losses, these stocks to buy made new 52-week highs. Maybe this is a signal that they will continue to head higher.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
This week started strong for GW Pharmaceuticals, as management continues to deliver on promises, so GWPH stock should continue to deliver profits.
GW Pharmaceuticals (GWPH) reported its latest quarterly earnings results after hours today, bringing in sales that surged more than 1200%.
From Market News Video
Investors in GW Pharmaceuticals plc (GWPH) saw new options become available this week, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Navellier RatingsPowered by Portfolio Grader